CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced an article covering FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF).

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6612/75312_196f8c2f4448b9a4_001.jpg


FinCanna Capital Corp.

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6612/75312_196f8c2f4448b9a4_001full.jpg

California is well known for its brand dominance-from its Hollywood studios to its Napa Valley wines. As a tastemaker across industries, the state’s cannabis brands are well-positioned to follow in these footsteps and expand across the United States if and when the federal government legalizes cannabis nationwide.

At the same time, manufactured products including gummies, chocolates, tinctures, personal care products and more, have experienced strong consumer demand and accelerating growth rate. More and more cannabis brands-in California and across the country-are expanding their product mix to include these new offerings. Contract manufacturers offer the easiest way to do so with minimal capital outlay or expertise required for brands looking to expand their presence on the dispensary shelf.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) has two core portfolio businesses, QVI Inc. and Cultivation Technologies Inc., that provide these critical supply and manufacturing services to cannabis companies. While they’ve launched their businesses in the branding capital, and largest market in the country, they are also positioned to expand nationally as legislation continues to offer the potential for expansion beyond state borders.

Let’s take a look at how California is dominating the cannabis brand landscape and companies that investors may want to consider for exposure, including FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) and its unique business model.

California’s Tastemaker Market

California is the largest cannabis market in the world with $4.4 billion in retail sales last year, according to Cannabis Business Plans, representing a nearly 50% growth rate over the prior year and nearly a third of all sales across the United States last year. By comparison, Colorado, Washington and Oregon combined represented less than 30% of all sales.

The sheer size of the market and ideal growing conditions have led to the creation of the country’s largest and most successful cannabis brands. The Golden State already supplies the majority of cannabis consumed in the United States and consolidation within the state is creating tomorrow’s industry giants.

While there are many companies offering investors exposure to these brands, FinCanna Capital Corp. has one of the most innovative business models. The company provides equipment and funding to cannabis companies in exchange for a royalty on future sales, generating high-margin recurring income for its shareholders.

The company’s royalty portfolio includes two innovative companies that are developing cannabis brands in California, including Cultivation Technologies Inc. and QVI Inc.

Cultivation Tech’s Growing Footprint

Cultivation Technologies Inc., operating under the brand Coachella Manufacturing, is a multi-award winning extraction and manufacturing enterprise located in Palm Desert, California that provides high-quality Butane Hash Oil (BHO) concentrates as well as higher velocity and higher volume white label manufacturing, toll processing and packaging services.

The company has a three-year operational history and FinCanna began receiving royalties during the second half of 2020. In February of 2021, FinCanna sold a portion of its unutilized extraction equipment to CTI in order to increase its production capacity by as much as 500% in exchange for an increase in royalty payments.

In addition to the new equipment, the company’s seasoned management team is working on growing the core business and expanding into other large-scale activities that they believe will result in a sizable increase in royalty revenue to FinCanna and its shareholders. The company’s unique facility and long client list paves the way for these opportunities.

Under the new agreement, FinCanna receives a 10% royalty on all revenue generated by CTI with 5% paid in cash every month and 5% deferred until certain trigger events. In addition, FinCanna receives another 10% royalty on all revenue generated by the newly sold extraction equipment, paid each month, until certain milestones are met.

Click here to receive an investor presentation and corporate updates

QVI’s Unique Products & Brands

QVI Inc., operating under the brand The Galley, is a cannabis-infused product manufacturer located in Sonoma, California. The company operates a fully-licensed 8,300 sq. ft. facility with a focus on edibles, topicals, tinctures, chocolates, hard candies, gummies, beverages, vapes, pre-rolls and flower packaging.

The company’s goal is to become California’s premier contract manufacturer, and upon success, license products throughout the country and global markets as legalization allows. In addition to being a one-stop shop to manufacture most high-value products, the company provides access to an outstanding R&D team with the ability to assist brands in launching new products.

The company’s team includes professional formulators and chefs with extensive experience in foods, beverages, candies and confections, as well as skincare and herbal medicine. Leveraging their deep expertise, the team is capable of helping companies with everything from sourcing cannabis to creating original formulations to designing the packaging materials.

QVI is targeting an annual operating capacity of approximately US$45 million with a growing roster of client brands. In February 2021, the company noted accelerating demand from over 30 in-state and out-of-state highly-regarded consumer brands, as well as a steady increase in re-orders from existing clients to generate recurring monthly revenue.

Under the terms of its agreement, FinCanna is scheduled to begin receiving royalty payments in 2021 amounting to 20% of QVI’s revenue paid in cash monthly. FinCanna will also receive annual supplemental payments that ensure that it receives a minimum of 70% of QVI’s annual after-tax net income paid in cash each year and 70% of the proceeds of any change of control or sale of the business.

Looking Ahead

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) has developed a unique business model that provides it with exposure to a growing portfolio of California brands. With royalty income coming on stream in 2020 and 2021, investors may want to take a closer look at the company as it transitions to profitable growth.

The company also recently announced a non-brokered private placement to raise $2 million from accredited investors and institutions. Each of the C$0.125 units will consist of a common share of FinCanna stock and one-half of one common share purchase warrant with an exercise price of C$0.18 and a 24 month expiration date.

Click here to receive an investor presentation and corporate updates

For FinCanna’s cautionary note regarding forward-looking information visit:

https://www.fincannacapital.com/corporate/forward-looking-statement/

Investor Relations:
Kin Communications
1-866-684-6730
CALI@kincommunications.com

For additional information visit www.fincannacapital.com.

Follow FinCanna on Twitter: @fincannacapital.

About CFN Enterprises Inc.

CFN Enterprises Inc. (OTCQB: CNFN) is a digital media and ecommerce company focused on advancing businesses and brands in highly regulated emerging industries across the globe. CFN connects investors with new market opportunities while helping consumers find innovative products that enhance their lives. Learn more at www.cfnenterprisesinc.com.

CFN Enterprises Inc. Media Contact:

CFN Enterprises Inc.
+001 (833) 420-CNFN
investors@cfnenterprisesinc.com

FORWARD-LOOKING STATEMENT

Use of Forward-looking Statements

This press release may contain forward-looking statements from CFN Enterprises Inc. within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, when CFN Enterprises Inc. describes FinCanna’s business, and uses other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions, CFN Enterprises Inc. is using forward-looking statements. These forward-looking statements are based on the current expectations of the management of CFN Enterprises Inc. only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial markets; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products and services; or, loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of CFN Enterprises Inc. to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, CFN Enterprises Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risk and uncertainties affecting CFN Enterprises Inc., reference is made to CFN Enterprises Inc.’s reports filed from time to time with the Securities and Exchange Commission.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/75312

News Provided by Newsfile via QuoteMedia

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less